Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
Comparative performance of the InBios SCoV-2 DetectTM IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations
Kutima B. et al, (2025), Wellcome Open Research, 9, 349 - 349
Uncovering the genetic diversity of the malaria parasite antigen MSP2 across Sub-Saharan Africa
Zerebinski J. et al, (2025)
Pf8: an open dataset of Plasmodium falciparum genome variation in 33,325 worldwide samples
Abdel Hamid MM. et al, (2025), Wellcome Open Research, 10, 325 - 325
Establishing laboratory reference ranges for haematological and biochemical blood parameters in adults and children in Kilifi, Kenya
Downs LO. et al, (2025), Wellcome Open Research, 10, 312 - 312
A pragmatic randomized controlled trial of standard care versus corticosteroids plus standard care for treatment of pneumonia in adults admitted to Kenyan hospitals (SONIA)
Lucinde R. et al, (2025), Wellcome Open Research, 7, 269 - 269
Low-Dose Yellow Fever Vaccine in Adults in Africa
Kimathi D. et al, (2025), New England Journal of Medicine, 392, 788 - 797
Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study
Kimotho J. et al, (2024), Wellcome Open Research, 8, 350 - 350
Identification of complex Plasmodium falciparum genetic backgrounds circulating in Africa: a multicountry genomic epidemiology analysis.
Miotto O. et al, (2024), The Lancet. Microbe
Prospective clinical surveillance for severe acute respiratory illness and COVID-19 vaccine effectiveness in Kenyan hospitals during the COVID-19 pandemic.
Lucinde RK. et al, (2024), BMC infectious diseases, 24
Effects of the COVID-19 pandemic on hospital admissions and inpatient mortality in Kenya: a retrospective cohort study
Ogero MO. et al, (2024), Wellcome Open Research, 9, 582 - 582
Establishing laboratory reference ranges for adults and children in Kilifi, Kenya
Downs LO. et al, (2024)
Antibodies to PfEMP1 and variant surface antigens: Protection after controlled human malaria infection in semi-immune Kenyan adults.
Kinyua AW. et al, (2024), The Journal of infection, 89
A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda.
Ogwang R. et al, (2024), Antimicrobial agents and chemotherapy, 68
The mRNA content of plasma extracellular vesicles provides a window into molecular processes in the brain during cerebral malaria
Kioko M. et al, (2024), Science Advances, 10
Full-length MSP1 is a major target of protective immunity after controlled human malaria infection.
Rosenkranz M. et al, (2024), Life science alliance, 7
Linking Cerebral Malaria Pathogenesis to APOE-Mediated Amyloidosis: Observations and Hypothesis.
Kioko M. et al, (2024), Molecular neurobiology
Comparative performance of the InBios SCoV-2 DetectTM IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations
Kutima B. et al, (2024), Wellcome Open Research, 9, 349 - 349